Glibenclamide Therapy in Diabetes Mellitus

Bhatia, S. K.; Hadden, D. R.; Montgomery, D. A. D.; Weaver, J. A.
June 1970
British Medical Journal;6/6/1970, Vol. 2 Issue 5709, p570
Academic Journal
No abstract available.


Related Articles

  • Glibenclamide.  // Reactions Weekly;11/3/2012, Issue 1426, p25 

    The article describes the case of an 81-year-old woman with type 2 diabetes mellitus who developed hypoglycaemia induced by glibenclamide therapy.

  • Glibenclamide.  // Reactions Weekly;6/1/2013, Issue 1455, p18 

    The article describes the case of a 51-year-old woman who experienced hypglycaemia while undergoing glibenclamide therapy for type 2 diabetes mellitus.

  • Glibenclamide plus metformin combination tablets are effective, convenient and well tolerated in the treatment of type 2 diabetes mellitus. Derosa, Giuseppe // Drugs & Therapy Perspectives;Aug2006, Vol. 22 Issue 8, p1 

    Combination therapy with an insulin-stimulating agent (i.e. glibenclamide [glyburide]) and an insulin-sensitising agent (i.e. metformin) is an optimal and rational therapeutic first- and second-line treatment in patients with type 2 diabetes mellitus. Single-tablet glibenclamide/metformin...

  • Glibenclamide/pioglitazone.  // Reactions Weekly;8/13/2011, Issue 1364, p23 

    The article describes the case of an elderly woman who developed hypoglycemia after receiving glibenclamide and pioglitazone for diabetes mellitus.

  • Glibenclamide.  // Reactions Weekly;12/19/2015, Vol. 1582 Issue 1, p223 

    The article describes the case of gastrointestinal reactions experienced by a patient following treatment with glibenclamide (glyburide) for neonatal diabetes mellitus.

  • Influence of CYP2C9 gene polymorphisms on response to glibenclamide in type 2 diabetes mellitus patients. Surendiran, A.; Pradhan, S.; Agrawal, Aparna; Subrahmanyam, D.; Rajan, S.; Anichavezhi, D.; Adithan, C. // European Journal of Clinical Pharmacology;Aug2011, Vol. 67 Issue 8, p797 

    Purpose: The antidiabetic drug glibenclamide is metabolized by the enzyme cytochrome P450 2C9 (CYP2C9) encoded by the polymorphic gene CYP2C9. Previous studies involving healthy volunteers have shown a significant influence of variant CYP2C9 genotypes on glibenclamide metabolism. The aim of this...

  • A case of a Japanese patient with neonatal diabetes mellitus caused by a novel mutation in the ABCC8 gene and successfully controlled with oral glibenclamide. Ryojun Takeda; Masaki Takagi; Kentaro Miyai; Hiroyuki Shinohara; Hiroko Yagi; Maki Moritani; Ichiro Yokota; Yukihiro Hasegawa // Clinical Pediatric Endocrinology;Oct2015, Vol. 24 Issue 4, p191 

    The article presents a case study of a Japanese patient who was diagnosed with permanent neonatal diabetes mellitus (PNDM) caused by ABCC8 gene mutation. A heterozygous missense mutation was detected through sequencing analysis. It mentions that the mutation was controlled with oral...

  • Metformin and glibenclamide: comparative risks. Campbell, I.W. // British Medical Journal (Clinical Research Edition);8/4/1984, Vol. 289 Issue 6440, p289 

    Examines the efficacy of metformin and glibenclamide for the management of non-insulin dependent diabetes mellitus in Europe. Availability of sulfonylurea preparation; Use of metformin as a risk in developing lactic acidosis; Action of glibenclamide for the induction of hypoglycemia.

  • Glibenclamide.  // Reactions Weekly;8/11/2012, Issue 1414, p28 

    The article describes the case of a 3-year-old girl who developed an allergic reaction during treatment with glibenclamide for diabetes mellitus.

  • Glibenclamide/glipizide.  // Reactions Weekly;Apr2015, Vol. 1547 Issue 1, p142 

    The article presents a case study of a two patients who experienced hypoglycaemic events (HE) while receiving glibenclamide and glipizide for type 2 diabetes mellitus.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics